Adaptive Biotechnologies to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Goldman Sachs 46^th Annual Global Healthcare Conference in Miami, FL.

Read more at globenewswire.com